Allosteric cross-talk in chromatin can mediate drug-drug synergy
Allostery and drug-drug synergism can yield potential novel therapies with existing molecules. Here, the authors provide evidence that two unrelated drugs have increased cytotoxicity in cancer cells, which coincides with increased formation of chromatin adducts.
Saved in:
Main Authors: | Zenita Adhireksan, Giulia Palermo, Tina Riedel, Zhujun Ma, Reyhan Muhammad, Ursula Rothlisberger, Paul J. Dyson, Curt A. Davey |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/9d1b4c81d2d84ca2b30e46381f058d95 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation
by: Gabriela E. Davey, et al.
Published: (2017) -
Near-atomic resolution structures of interdigitated nucleosome fibres
by: Zenita Adhireksan, et al.
Published: (2020) -
Optimal drug synergy in antimicrobial treatments.
by: Joseph Peter Torella, et al.
Published: (2010) -
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
by: Per Plenge, et al.
Published: (2021) -
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
by: Ingrid Langer, et al.
Published: (2021)